IIA
CELG

IPG Investment Advisors’s Celgene Corp CELG Stock Holding History

IPG Investment Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,195
Closed -$320K – 176
2017
Q3 		$320K Buy
+2,195
New +$299K 0.11% 95

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

IPG Investment Advisors's CELG Position: Q4 2017 in Review

IPG Investment Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 2,195 shares — an estimated $320K sold.

IPG Investment Advisors first reported a position in CELG in Q3 2017 and held it in 1 quarter. The position peaked at $320K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • IPG Investment Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • IPG Investment Advisors sold 2,195 Celgene Corp shares in Q4 2017, an estimated $320K.
  • IPG Investment Advisors first reported a position in Celgene Corp in Q3 2017 and held it in 1 quarter.
  • IPG Investment Advisors's Celgene Corp position peaked at $320K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on IPG Investment Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.